Carisma Therapeutics, Inc.CARMNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$13.66M
↑ 135% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
$-38.89M
Historical baseline
PeriodValueYoY Change
TTM$13.66M+124.0%
2024$-56.83M+33.8%
2023$-85.89M-52.9%
2022$-56.19M-559.2%
2021$-8.52M+69.5%
2020$-27.93M+74.0%
2019$-107.28M-220.4%
2018$-33.48M-16.5%
2017$-28.74M-1338.4%
2016$2.32M-